Biocon shares fall 2.01%; stock among top losers on Nifty Midcap 150

Shares of Biocon experienced a decline of 2.01% to Rs 386.70 in Tuesday's session, with the stock figuring among the top losers on the Nifty Midcap 150. This movement reflects a decrease from its previous close.Financial Snapshot

The following table presents a summary of the company's consolidated financial performance:

ParticularsMar 2021Mar 2022Mar 2023Mar 2024

Mar 2025Revenue (Rs Crore)7,105.808,184.0011,174.2014,755.70

15,261.70Net Profit (Rs Crore)925.40978.50810.001,382.00

1,429.40EPS6.245.443.888.55

8.46

The company's consolidated revenue increased by 3.43%, from Rs 14,755.70 Crore in March 2024 to Rs 15,261.70 Crore in March 2025. Net profit also saw an increase of 3.43%, rising from Rs 1,382.00 Crore to Rs 1,429.40 Crore during the same period. Basic EPS stood at Rs 8.46 in March 2025.Quarterly Financial Highlights

Here’s a look at the consolidated quarterly performance of Biocon:

ParticularsMar 2024Jun 2024Sep 2024Dec 2024

Mar 2025Revenue (Rs Crore)3,917.103,432.903,590.403,821.40

4,417.00Net Profit (Rs Crore)225.60861.8027.1081.10

459.40EPS1.135.51-0.130.21

2.88

The revenue for the quarter-ending March 2025 stood at Rs 4,417.00 Crore, a 12.76% increase from Rs 3,917.10 Crore in the quarter-ending March 2024. The net profit for the quarter-ending March 2025 was Rs 459.40 Crore, compared to Rs 225.60 Crore in the corresponding quarter of the previous year.

Key Financial Ratios (Consolidated)

RatioMar 2021Mar 2022Mar 2023Mar 2024

Mar 2025Debt to Equity (x)0.470.580.990.80

0.82Return on Networth / Equity (%)9.837.692.585.16

4.68P/E (x)65.5361.6953.1830.89

40.39

The company reported a debt-to-equity ratio of 0.82 as of March 2025, slightly higher than the 0.80 reported in March 2024. The return on net worth stood at 4.68% as of March 2025. The P/E ratio is 40.39 as of March 2025.Corporate Actions

Biocon announced a final dividend of Rs 0.50 per share (10%) on May 8, 2025, with an ex-date of July 4, 2025. The company had also announced bonus issues in the past, including a 1:1 bonus on April 25, 2019. Prior to that, a bonus issue of 2:1 was announced on April 27, 2017.With the stock's last traded price at Rs 386.70, Biocon has seen a decline during today's session.